Product References — Pooled Human Plasma (Blood Derived)

BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells

Posted by Adam Awdish on

BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   BMI1 Enables Extensive Expansion of Functional Erythroblasts from Human Peripheral Blood Mononuclear Cells Senquan Liu, Mengyao Wu, Moira Lancelot, Jiusheng Deng, Yongxing Gao, John D. Roback, Tong Chen, and Linzhao Cheng Molecular Therapy May 5, 2021 One of the most common treatments for patients with anemia or suffering from major blood loss is a red blood cell (RBC) transfusion from an ABO-matched donor. However, the number of cases that require these transfusions is increasing yearly, creating a growing need for blood donations amid blood shortages...

Read more →

Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer

Posted by Adam Awdish on

Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer Eiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, Daisuke Saigusa, Bin Li, Kei Kudo, Keita Tsuji, Shogo Shigeta, Hideki Tokunaga, Kazuki Kumada, Keigo Komine, Hidekazu Shirota, Yuichi Aoki, Ikuko N. Motoike, Jun Yasuda, Kengo Kinoshita, Masayuki Yamamoto, Seizo Koshiba, and Nobuo Yaegashi Toxins June 30, 2021 Epithelial ovarian cancer (EOC) is a gynecological cancer with a high mortality rate, with a 5-year survival rate below 50%. Standard treatment for advanced EOC includes a combination...

Read more →

α-Synuclein in Blood Exosomes Immunoprecipitated Using Neuronal and Oligodendroglial Markers Distinguishes Parkinson’s Disease from Multiple System Atrophy

Posted by Adam Awdish on

α-Synuclein in Blood Exosomes Immunoprecipitated Using Neuronal and Oligodendroglial Markers Distinguishes Parkinson’s Disease from Multiple System Atrophy

Pooled Human Plasma (Blood Derived) and Pooled Human Serum Off the Clot from Innovative Research were used in the following study:   α-Synuclein in Blood Exosomes Immunoprecipitated Using Neuronal and Oligodendroglial Markers Distinguishes Parkinson’s Disease from Multiple System Atrophy Suman Dutta, Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish del Rosario, Kimberly C. Paul, Darice Y. Wong, Aline Duarte Folle, Daniela Markovic, Jose-Alberto Palma, Geidy E. Serrano, Charles H. Adler, Susan L. Perlman, Wayne W. Poon, Un Jung Kang, Roy N. Alcalay, Miriam Sklerov, Karen H. Gylys, Horacio Kaufmann, Brent L. Fogel, Jeff M. Bronstein, Beate Ritz & Gal Bitan...

Read more →

A Universal Anti-Xa Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements: Method Validation, Diagnostic Accuracy and External Validation

Posted by Adam Awdish on

A Universal Anti-Xa Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements: Method Validation, Diagnostic Accuracy and External Validation

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   A Universal Anti-Xa Assay for Rivaroxaban, Apixaban, and Edoxaban Measurements: Method Validation, Diagnostic Accuracy and External Validation Guido Willekens, Jan-Dirk Studt, Adriana Mendez, Lorenzo Alberio, Pierre Fontana, Walter A. Wuillemin, Adrian Schmidt, Lukas Graf, Bernhard Gerber, Cedric Bovet, Thomas C. Sauter, and Michael Nagler British Journal of Haematology March 19, 2021 When it comes to medical treatments and emergency care, any treatment involving anticoagulants naturally carries the risk of increased bleeding. In fact, uncontrolled bleeding is the leading cause of death in trauma patients. Knowing...

Read more →

A New Promising Anti-Infective Agent Inhibits Biofilm Growth by Targeting Simultaneously a Conserved RNA Function That Controls Multiple Genes

Posted by Adam Awdish on

A New Promising Anti-Infective Agent Inhibits Biofilm Growth by Targeting Simultaneously a Conserved RNA Function That Controls Multiple Genes

Pooled Human Plasma (Blood Derived) from Innovative Research was used in the following study:   A New Promising Anti-Infective Agent Inhibits Biofilm Growth by Targeting Simultaneously a Conserved RNA Function That Controls Multiple Genes Thorsten M. Seyler, Christina Moore, Haein Kim, Sheetal Ramachandran and Paul F. Agris Antibiotics January 4, 2021 An immediate contemporary challenge in the field of medicine is that of combating drug-resistant infections in the form of biofilms. Due to the diverse population of bacteria that can cause infection and their constantly evolving defense mechanisms, there is a lot of focus on developing new treatments that are...

Read more →


×